Securities America settles with state in conditional resolution of Reg D mess

Putting an end to a bitter dispute over the sale of failed private placements, Securities America Inc. has agreed to make whole 63 Massachusetts clients who bought $5 million of failed notes issued by Medical Capital Holdings Inc.
JUL 26, 2011
Putting an end to a bitter dispute over the sale of failed private placements, Securities America Inc. has agreed to make whole 63 Massachusetts clients who bought $5 million of failed notes issued by Medical Capital Holdings Inc. Securities America, which is being shopped by its owner, Ameriprise Financial Inc., agreed to pay $2.8 million to clients within 10 days, William F. Galvin, secretary of the commonwealth of Massachusetts, said in a statement last week. The settlement is, in part, conditional. Securities America could be on the hook for up to another $2.2 million if a class action settlement before a federal judge in Dallas falls through, according to Mr. Galvin's statement. Securities America also could pay more to investors if the receiver for Medical Capital fails to pay 10% back to investors. Massachusetts investors in the end will get back 100% of the $5 million in principal lost in Medical Capital, which the Securities and Exchange Commission charged with fraud in 2009. Dozens of independent broker-dealers sold the MedCap notes, with Securities America by far the largest distributor, raising about $700 million from 2003 to 2008. About half that investor money was lost in the alleged fraud. The settlement strikes a different note than Securities America initially took with the Massachusetts Securities Division, which charged the firm in January 2010 with selling the MedCap notes without telling investors that they were high-risk investments. Lawyers and executives with the firm have consistently said that the firm did industry-leading due diligence about the product, a high-risk, Reg D private placement, and that the blame for the product's failure lies with Medical Capital. The securities division also charged that Securities America's sales tactics ignored warnings of the firm's own analysts. In addition, the regulator claimed that the brokerage pitched the notes to unsophisticated investors. “Securities America is pleased to be another step closer to final resolution of the Medical Capital matter,” spokeswoman Janine Wertheim said in a statement. “The settlement with Massachusetts does not include any fines against Securities America, and in agreeing to the settlement, we did not acknowledge any wrongdoing in this matter.” Although Ms. Wertheim said that the alleged fraud was committed by the principals of Medical Capital, she added: “We believe the settlement to be the best method of resolving the matter.” E-mail Bruce Kelly at [email protected].

Latest News

The 2025 InvestmentNews Awards Excellence Awardees revealed
The 2025 InvestmentNews Awards Excellence Awardees revealed

From outstanding individuals to innovative organizations, find out who made the final shortlist for top honors at the IN awards, now in its second year.

Top RIA Cresset warns of 'inevitable' recession amid tariff uncertainty
Top RIA Cresset warns of 'inevitable' recession amid tariff uncertainty

Cresset's Susie Cranston is expecting an economic recession, but says her $65 billion RIA sees "great opportunity" to keep investing in a down market.

Edward Jones joins the crowd to sell more alternative investments
Edward Jones joins the crowd to sell more alternative investments

“There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said.

Record RIA M&A activity marks strong start to 2025
Record RIA M&A activity marks strong start to 2025

Sellers shift focus: It's not about succession anymore.

IB+ Data Hub offers strategic edge for U.S. wealth advisors and RIAs advising business clients
IB+ Data Hub offers strategic edge for U.S. wealth advisors and RIAs advising business clients

Platform being adopted by independent-minded advisors who see insurance as a core pillar of their business.

SPONSORED Compliance in real time: Technology's expanding role in RIA oversight

RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.

SPONSORED Advisory firms confront crossroads amid historic wealth transfer

As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.